– HIV and AIDS Main Section
  FDA-approved Treatments
  Experimental Treatments
  Top New Articles

HIV and AIDS Top News Articles
Benefits of Adding Viral Load or CD4 Cell Count Monitoring to Clinical Monitoring Alone Are Modest - 5/16/08
Does Tenofovir (Viread) Increase Liver Toxicity Related to Efavirenz (Sustiva)? - 5/16/08
Body Fat and Blood Lipid Levels in Men and Women with HIV - 5/16/08
Body Shape Changes in HIV Positive and HIV Negative Women - 5/16/08
Worsening Cardiovascular Risk among HIV Positive Individuals in D:A:D Study Has Not Led to an Increase in Heart Attacks - 5/13/08
Interaction between Lopinavir-ritonavir (Kaletra) and Rosuvastatin (Crestor) Reduces Drug's Lipid-lowering Effect - 5/13/08
Antiretroviral Therapy and Other Interventions Can Nearly Eliminate Risk of Mother-to-Child HIV Transmission - 5/13/08
Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies - 5/09/08
Rapid Scale-up of Antiretroviral Therapy in South Africa Could Reduce HIV/AIDS Deaths by 1.3 Million by Year 2012 - 5/09/08
Higher CD4 Count Predicts Lower Risk of AIDS-related and Non-AIDS Illness, even above 350 Cells/mm3 - 5/06/08
Patients with CXCR4-tropic or Mixed-tropic HIV Experience Faster CD4 Cell Decline and May Benefit from Earlier Treatment - 5/06/08
NIAID Research Priorities to Fight Drug-resistant Tuberculosis - 5/06/08
Treatment Options for Osteopenia and Osteoporosis in HIV Patients - 5/02/08
HLA B*5701 Genetic Test Predicts Abacavir Hypersensitivity in Black as well as White HIV Patients - 5/02/08
Genetic Variation Predicts Higher Risk of Lipoatrophy in Patients on HAART - 5/02/08
Interrupting Antiretroviral Therapy Does Not Reduce the Risk of Cardiovascular Disease: Final Results of ACTG 5102 - 4/29/08
Tolerability and Effectiveness of First-line Treatment with Nevirapine and Lamivudine plus Zidovudine or Stavudine - 4/29/08
Efficacy and Safety of Once-daily Regimens in the Treatment of HIV Infection - 4/24/08
Following Antiretroviral Treatment Guidelines Produces the Best Results in Women with HIV - 4/24/08
Interactions between the Anti-fungal Agent Voriconazole (Vfend) and Antiretroviral Drugs- 4/24/08
Researchers Develop Breath Analyzer to Monitor Treatment Adherence - 4/24/08
Selected Highlights from the 9th International Workshop on Clinical Pharmacology of HIV Therapy - 4/18/08
CD4 Cell Recovery after Initiation of HAART in Treatment-naive Patients - 4/18/08
Fish Oil with or without Fenofibrate Reduces Elevated Triglycerides in HIV Patients on HAART - 4/18/08
Certain Maternal and Child HLA Patterns Increase Risk of Vertical HIV Transmission - 4/18/08
Schering-Plough Initiates Phase II Study with Vicriviroc in Treatment-naïve HIV-infected Patients  - 4/16/08
Resistance Profile of the New Protease Inhibitor Darunavir (Prezista)  - 4/15/08
Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk  - 4/15/08
Anti-inflammatory Drug Salsalate May Improve Blood Vessel Dysfunction in People with HIV  - 4/15/08
New Report Says 2.1 Million Children Worldwide Are Living with HIV/AIDS  - 4/15/08
European Symposium on Patient Compliance and Persistence (ESPACOMP) Set for September 5, 2008 in Basel, Switzerland  - 4/15/08
Management of HIV Positive Men with Prostate Cancer in the HAART Era  - 4/11/08
Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08
Lower-Strength Lopinavir/Ritonavir (Kaletra, Aluvia) Tablet Approved in Europe for Children with HIV  - 4/11/08
Federal Government Announces $1.1 Billion in Ryan White Grants for HIV/AIDS Care and Services  - 4/11/08
Report Examines Progress and Challenges Facing State AIDS Drug Assistance Programs (ADAPs)  - 4/11/08
"Women Living Positive: It's My Life" National Summit Webcast  - 4/11/08
Human Genetic Variations Predict Response to Antiretroviral Therapy - 4/04/08
Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children - 4/04/08
New amFAR Survey Reveals HIV Positive Women Still Face Stigma - 4/04/08
Argos Therapeutics Reports Promising Phase 1 Data on AGS-004 Immunotherapy for HIV - 4/04/08
Is There a Potential Role for Ritonavir-boosted Protease Inhibitor Monotherapy? - 4/01/08
TMP-SMX Remains the Therapeutic Drug of Choice for HIV-related PCP in First- and Second-line Settings - 4/01/08
Latest CDC Figures Show More Diagnosed HIV Cases, but Not More New Infections - 4/01/08
New Network Will Send Drug Alerts Instantly to U.S. Doctors via Email - 4/01/08
FDA Issues Safety Review of Ziagen and Videx; GlaxoSmithKline Responds - 3/28/08
Registration Opens for 17th International AIDS Conference (AIDS 2008) in Mexico City, August 3-8, 2008 - 3/28/08
U.S. Government-sponsored HIV Vaccine Research Faces Setbacks - 3/28/08
Tenofovir (Viread) Is Better Tolerated than AZT (Retrovir) as Part of a Post-exposure Prophylaxis Regimen - 3/28/08
Cost Effectiveness of Truvada versus Combivir, Both in Combination with Efavirenz (Sustiva) - 3/28/08
New Pediatric Dosing Recommendations for Atazanavir (Reyataz) - 3/28/08
FDA Warns Consumers Not to Use Products Sold Over the Internet for Erectile Dysfunction - 3/28/08
Nevirapine (Viramune) versus Abacavir (Ziagen) in Combination with AZT/3TC (Combivir) as First-line Antiretroviral Therapy - 3/21/08
Determinants of HIV Progression and Assessment of Optimal Time to Start HAART: PISCIS Study - 3/21/08
Anal Cancer Risk Remains High among HIV Positive Men and Women on HAART: SUN Study - 3/21/08
Efficacy and Safety of Dual Protease Inhibitor Regimens for the Treatment of Antiretroviral-naive HIV Patients - 3/18/08
NNRTI-based Therapy Yields High Response Rates despite Prior Exposure to Single-dose Nevirapine (Viramune) - 3/18/08
Antiretroviral Therapy Is Not a Risk Factor for Hypogonadism in HIV Positive Men - 3/18/08
U.S. Syphilis Rate Rises for 7th Year in a Row, Testing Is Inadequate for Gay and Bisexual Men, and STD Rates Are High among Young Women - 3/18/08
Second Study Fails to Show Benefit of Herpes Treatment for Preventing HIV Infection - 3/18/08
Low Levels of HIV Persist for at Least 7 Years despite Effective Antiretroviral Therapy - 3/14/08
Growth Hormone May Boost Thymic Function and Increase CD4 Cell Count - 3/14/08
Growth Hormone and GH Releasing Factor (Tesamorelin) for HIV-related Lipodystrophy - 3/14/08
FDA Warns Companies Selling Drugs on the Internet that Falsely Claim to Prevent and Treat STDs, including HIV/AIDS - 3/14/08
Tibotec and FDA Warn of Liver Toxicity Linked to Ritonavir-boosted Darunavir (Prezista) - 3/12/08
Maraviroc (Selzentry) Has Minimal Effect on Lipid Profiles - 3/11/08
 
 
 
 
 
 
 
 
 
 
 
 
 

Sign up to receive our
twice-weekly e-Newsletter

Reports on Most Recent HIV and AIDS
Research Conferences

CROI 2008 - Feb. 2008 
IAS 2007 - July 2007 

Protease Inhibitors
Agenerase
Agenerase (amprenavir)
Aptivus
Aptivus (tipranavir)
Crixivan
Crixivan (indinavir)
Invirase
Invirase (saquinavir hard gel)
Kaletra
Kaletra (lopinavir/ritonavir)
Lexiva
Lexiva (fosamprenavir)
Norvir
Norvir (ritonavir)
Prezista
Prezista (darunavir)
Reyataz
Reyataz (atazanavir)
Viracept
Viracept (nelfinavir)
Nucleoside / Nucleotide Reverse Transcriptase Inhibitors
Combivir
Combivir (zidovudine/lamivudine)
Epivir
Epivir (lamivudine; 3TC)
Emtriva
Emtriva (emtricitabine; FTC)
Epzicom
Epzicom (abacavir + lamivudine)
Retrovir
Retrovir (zidovudine; AZT)
Trizivir
Trizivir (abacavir + zidovudine +lamivudine)
Truvada
Truvada  (tenofovir / emtricitabine)
Videx
Videx (didanosine; ddI)
Viread
Viread (tenofovir)
Zerit
Zerit (stavudine; d4T)
Ziagen
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Rescriptor
Etravirine (Intelence; TMC125)
Rescriptor
Rescriptor (delavirdine)
Sustiva
Sustiva (efavirenz)
Viramune
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry ( maraviroc)
Fixed-dose Combinations
Atripla
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir
Combivir (zidovudine + lamivudine)
Trizivir
Trizivir (abacavir + zidovudine + lamivudine)
Truvada
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  
  

 

HIV and AIDS Top News Articles
Worsening Cardiovascular Risk among HIV Positive Individuals in D:A:D Study Has Not Led to an Increase in Heart Attacks - 5/13/08
Interaction between Lopinavir-ritonavir (Kaletra) and Rosuvastatin (Crestor) Reduces Drug's Lipid-lowering Effect - 5/13/08
Antiretroviral Therapy and Other Interventions Can Nearly Eliminate Risk of Mother-to-Child HIV Transmission - 5/13/08
Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies - 5/09/08
Rapid Scale-up of Antiretroviral Therapy in South Africa Could Reduce HIV/AIDS Deaths by 1.3 Million by Year 2012 - 5/09/08
Higher CD4 Count Predicts Lower Risk of AIDS-related and Non-AIDS Illness, even above 350 Cells/mm3 - 5/06/08
Patients with CXCR4-tropic or Mixed-tropic HIV Experience Faster CD4 Cell Decline and May Benefit from Earlier Treatment - 5/06/08
NIAID Research Priorities to Fight Drug-resistant Tuberculosis - 5/06/08
Treatment Options for Osteopenia and Osteoporosis in HIV Patients - 5/02/08
HLA B*5701 Genetic Test Predicts Abacavir Hypersensitivity in Black as well as White HIV Patients - 5/02/08
Genetic Variation Predicts Higher Risk of Lipoatrophy in Patients on HAART - 5/02/08
Interrupting Antiretroviral Therapy Does Not Reduce the Risk of Cardiovascular Disease: Final Results of ACTG 5102 - 4/29/08
Tolerability and Effectiveness of First-line Treatment with Nevirapine and Lamivudine plus Zidovudine or Stavudine - 4/29/08
Efficacy and Safety of Once-daily Regimens in the Treatment of HIV Infection - 4/24/08
Following Antiretroviral Treatment Guidelines Produces the Best Results in Women with HIV - 4/24/08
Interactions between the Anti-fungal Agent Voriconazole (Vfend) and Antiretroviral Drugs- 4/24/08
Researchers Develop Breath Analyzer to Monitor Treatment Adherence - 4/24/08
Selected Highlights from the 9th International Workshop on Clinical Pharmacology of HIV Therapy - 4/18/08
CD4 Cell Recovery after Initiation of HAART in Treatment-naive Patients - 4/18/08
Fish Oil with or without Fenofibrate Reduces Elevated Triglycerides in HIV Patients on HAART - 4/18/08
Certain Maternal and Child HLA Patterns Increase Risk of Vertical HIV Transmission - 4/18/08
Schering-Plough Initiates Phase II Study with Vicriviroc in Treatment-naïve HIV-infected Patients  - 4/16/08
Resistance Profile of the New Protease Inhibitor Darunavir (Prezista)  - 4/15/08
Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk  - 4/15/08
Anti-inflammatory Drug Salsalate May Improve Blood Vessel Dysfunction in People with HIV  - 4/15/08
New Report Says 2.1 Million Children Worldwide Are Living with HIV/AIDS  - 4/15/08
European Symposium on Patient Compliance and Persistence (ESPACOMP) Set for September 5, 2008 in Basel, Switzerland  - 4/15/08
Management of HIV Positive Men with Prostate Cancer in the HAART Era  - 4/11/08
Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08
Lower-Strength Lopinavir/Ritonavir (Kaletra, Aluvia) Tablet Approved in Europe for Children with HIV  - 4/11/08
Federal Government Announces $1.1 Billion in Ryan White Grants for HIV/AIDS Care and Services  - 4/11/08
Report Examines Progress and Challenges Facing State AIDS Drug Assistance Programs (ADAPs)  - 4/11/08
"Women Living Positive: It's My Life" National Summit Webcast  - 4/11/08
Human Genetic Variations Predict Response to Antiretroviral Therapy - 4/04/08
Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children - 4/04/08
New amFAR Survey Reveals HIV Positive Women Still Face Stigma - 4/04/08
Argos Therapeutics Reports Promising Phase 1 Data on AGS-004 Immunotherapy for HIV - 4/04/08
Is There a Potential Role for Ritonavir-boosted Protease Inhibitor Monotherapy? - 4/01/08
TMP-SMX Remains the Therapeutic Drug of Choice for HIV-related PCP in First- and Second-line Settings - 4/01/08
Latest CDC Figures Show More Diagnosed HIV Cases, but Not More New Infections - 4/01/08
New Network Will Send Drug Alerts Instantly to U.S. Doctors via Email - 4/01/08
FDA Issues Safety Review of Ziagen and Videx; GlaxoSmithKline Responds - 3/28/08
Registration Opens for 17th International AIDS Conference (AIDS 2008) in Mexico City, August 3-8, 2008 - 3/28/08
U.S. Government-sponsored HIV Vaccine Research Faces Setbacks - 3/28/08
Tenofovir (Viread) Is Better Tolerated than AZT (Retrovir) as Part of a Post-exposure Prophylaxis Regimen - 3/28/08
Cost Effectiveness of Truvada versus Combivir, Both in Combination with Efavirenz (Sustiva) - 3/28/08
New Pediatric Dosing Recommendations for Atazanavir (Reyataz) - 3/28/08
FDA Warns Consumers Not to Use Products Sold Over the Internet for Erectile Dysfunction - 3/28/08
Nevirapine (Viramune) versus Abacavir (Ziagen) in Combination with AZT/3TC (Combivir) as First-line Antiretroviral Therapy - 3/21/08
Determinants of HIV Progression and Assessment of Optimal Time to Start HAART: PISCIS Study - 3/21/08
Anal Cancer Risk Remains High among HIV Positive Men and Women on HAART: SUN Study - 3/21/08
Efficacy and Safety of Dual Protease Inhibitor Regimens for the Treatment of Antiretroviral-naive HIV Patients - 3/18/08
NNRTI-based Therapy Yields High Response Rates despite Prior Exposure to Single-dose Nevirapine (Viramune) - 3/18/08
Antiretroviral Therapy Is Not a Risk Factor for Hypogonadism in HIV Positive Men - 3/18/08
U.S. Syphilis Rate Rises for 7th Year in a Row, Testing Is Inadequate for Gay and Bisexual Men, and STD Rates Are High among Young Women - 3/18/08
Second Study Fails to Show Benefit of Herpes Treatment for Preventing HIV Infection - 3/18/08
Low Levels of HIV Persist for at Least 7 Years despite Effective Antiretroviral Therapy - 3/14/08
Growth Hormone May Boost Thymic Function and Increase CD4 Cell Count - 3/14/08
Growth Hormone and GH Releasing Factor (Tesamorelin) for HIV-related Lipodystrophy - 3/14/08
FDA Warns Companies Selling Drugs on the Internet that Falsely Claim to Prevent and Treat STDs, including HIV/AIDS - 3/14/08
Tibotec and FDA Warn of Liver Toxicity Linked to Ritonavir-boosted Darunavir (Prezista) - 3/12/08
Maraviroc (Selzentry) Has Minimal Effect on Lipid Profiles - 3/11/08